FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

PLoS ONE - United States
doi 10.1371/journal.pone.0013821
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The Opposite Association of HRAS and KRAS Mutations With Clinical Variables of Bladder Cancer

Vavilov Journal of Genetics and Breeding
2015English

Biomarkers for Detection and Surveillance of Bladder Cancer

Canadian Urological Association Journal
Urology
2013English

KRAS, HRAS and EGFR Mutations in Sporadic Sebaceous Gland Hyperplasia

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Vitamin D Receptor Expression Is Associated With PIK3CA and KRAS Mutations in Colorectal Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Analysis of Mutations in the PIK3CA and FGFR3 Genes in Verrucous Epidermal Nevus

Anais Brasileiros de Dermatologia
Dermatology
2013English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

PLoS ONE
Multidisciplinary
2014English

The Potential of MiRNAs as Biomarkers and Therapy Targets for Cancer

Journal Of Medicine & Health
2016English

BRAF, KRAS and PIK3CA Mutations in Colorectal Serrated Polyps and Cancer: Primary or Secondary Genetic Events in Colorectal Carcinogenesis?

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Evaluation of KRAS, NRAS and BRAF Mutations Detection in Plasma Using an Automated System for Patients With Metastatic Colorectal Cancer

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy